NA Cervical Cancer Diagnostic Market - Industry Trends and Forecast to 2030
Market Report I 2022-11-01 I 157 Pages I Data Bridge Market Research
The North America cervical cancer diagnostic market is projected to register a substantial CAGR of 7.0% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030
Market Segmentation:
North America Cervical Cancer Diagnostic Market, By Product Type (Imaging Test, Screening Test, Visual Examination, Cervical Biopsies, and Other Procedures), Age Group (Below 21, 21-29, 30-65, 65 and Above), Stages (Stage I, Stage II, Stage III, Stage IV), End Users (Hospitals, Diagnostic Laboratories, Specialty Clinics, Community Health Centers, Cancer Research Organization, Cancer and Radiation Therapy Centers), Distribution Channel (Direct Tender, Retail Sales, Online Sales), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the North America cervical cancer diagnostic market are:
- Established healthcare system
- Presence of big market players
Market Players:
Some key market players in the North America cervical cancer diagnostic market are listed below:
- Siemens Healthcare GmbH
- BD
- F. Hoffmann-La Roche Ltd
- Abbott
- Hologic, Inc.
- Quest Diagnostics Incorporated
- Bio-Rad Laboratories, Inc.
- QIAGEN
- The Cooper Companies Inc.
- Seegene Inc.
- Sysmex Corporation
- MobileODT
- Guided Therapeutics, Inc.
- GenomeMe Lab Inc.
- Arbor Vita Corporation
TABLE OF CONTENTS
1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.3 OVERVIEW OF NORTH AMERICA CERVICAL CANCER DIAGNOSTIC MARKET 33
1.4 LIMITATIONS 35
1.5 MARKETS COVERED 35
2 MARKET SEGMENTATION 37
2.1 MARKETS COVERED 37
2.2 GEOGRAPHICAL SCOPE 38
2.3 YEARS CONSIDERED FOR THE STUDY 39
2.4 CURRENCY AND PRICING 39
2.5 DBMR TRIPOD DATA VALIDATION MODEL 40
2.6 MULTIVARIATE MODELLING 43
2.7 PRODUCT TYPE LIFELINE CURVE 43
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 44
2.9 DBMR MARKET POSITION GRID 45
2.10 MARKET END USER COVERAGE GRID 46
2.11 VENDOR SHARE ANALYSIS 47
2.12 SECONDARY SOURCES 48
2.13 ASSUMPTIONS 48
3 EXECUTIVE SUMMARY 49
4 PREMIUM INSIGHTS 51
4.1 PESTEL ANALYSIS 52
4.2 PORTER'S FIVE FORCES MODEL 53
4.3 INDUSTRY INSIGHTS: 54
4.3.1 CERVICAL CANCER DIAGNOSIS 55
4.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS 55
5 REGULATORY FRAMEWORK 57
6 MARKET OVERVIEW 59
6.1 DRIVERS 61
6.1.1 INCREASING PREVALENCE AND INCIDENCE OF CERVICAL CANCER 61
6.1.2 RISING AWARENESS OF EARLY DIAGNOSIS OF CERVICAL CANCER 61
6.1.3 HIGH PREVALENCE OF HPV-INFECTED PATIENTS AND RISING INCIDENCE OF TEENAGE SEXUAL ENCOUNTERS 62
6.2 RESTRAINTS 62
6.2.1 DEVELOPMENT IN THE FIELD OF HPV VACCINE 62
6.2.2 SIDE EFFECTS OF TREATMENT DRUGS 62
6.3 OPPORTUNITIES 63
6.3.1 RISING HEALTHCARE EXPENDITURE 63
6.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS 63
6.4 CHALLENGES 64
6.4.1 STRINGENT RULES AND REGULATIONS 64
6.4.2 FALSE RESULTS IN SCREENING TESTS AND UNAVAILABILITY OF IMPROVED HEALTHCARE INFRASTRUCTURE 65
7 NORTH AMERICA CERVICAL CANCER DIAGNOSTIC MARKET, BY PRODUCT TYPE 66
7.1 OVERVIEW 67
7.2 SCREENING TEST 70
7.2.1 HPV TEST 71
7.2.1.1 ASSAYS 71
7.2.1.2 KITS/REAGENTS 71
7.2.2 PAP TEST 71
7.2.2.1 ASSAYS 71
7.2.2.2 KITS/REAGENTS 71
7.2.3 BLOOD TEST 72
7.3 IMAGING TEST 72
7.3.1 PET CT-SCAN 73
7.3.2 MAGNETIC RESONANCE IMAGING (MRI) 73
7.3.3 ULTRASOUND 73
7.3.4 X-RAY 73
7.3.5 OTHERS 73
7.4 CERVICAL BIOPSIES 73
7.4.1 LIQUID BIOPSY 74
7.4.2 ENDOCERVICAL CURETTAGE 74
7.4.3 COLPOSCOPIC BIOPSY 74
7.5 VISUAL EXAMINATION 74
7.5.1 CYSTOSCOPY 75
7.5.2 SIGMOIDOSCOPY 75
7.6 OTHER PROCEDURES 76
8 NORTH AMERICA CERVICAL CANCER DIAGNOSTIC MARKET, BY AGE GROUP 77
8.1 OVERVIEW 78
8.2 30-65 81
8.3 65 AND ABOVE 81
8.4 21-29 82
8.5 BELOW 21 83
9 NORTH AMERICA CERVICAL CANCER DIAGNOSTIC MARKET, BY STAGES 84
9.1 OVERVIEW 85
9.2 STAGE I 88
9.3 STAGE II 88
9.4 STAGE III 89
9.5 STAGE IV 90
10 NORTH AMERICA CERVICAL CANCER DIAGNOSTIC MARKET, BY END USER 91
10.1 OVERVIEW 92
10.2 CANCER AND RADIATION THERAPY CENTERS 95
10.3 HOSPITALS 95
10.4 SPECIALTY CLINICS 96
10.5 CANCER RESEARCH ORGANIZATION 97
10.6 DIAGNOSTIC LABORATORIES 97
10.7 COMMUNITY HEALTH CENTERS 98
11 NORTH AMERICA CERVICAL CANCER DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL 99
11.1 OVERVIEW 100
11.2 DIRECT TENDER 103
11.3 RETAIL SALES 103
11.4 ONLINE SALES 104
12 NORTH AMERICA CERVICAL CANCER DIAGNOSTIC MARKET, BY REGION 105
12.1 NORTH AMERICA 106
12.1.1 U.S. 114
12.1.2 CANADA 117
12.1.3 MEXICO 120
13 NORTH AMERICA CERVICAL CANCER DIAGNOSTIC MARKET: COMPANY LANDSCAPE 123
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 123
14 SWOT ANALYSIS 124
15 COMPANY PROFILE 125
15.1 SIEMENS HEALTHCARE GMBH 125
15.1.1 COMPANY SNAPSHOT 125
15.1.2 REVENUE ANALYSIS 125
15.1.3 COMPANY SHARE ANALYSIS 126
15.1.4 PRODUCT PORTFOLIO 126
15.1.5 RECENT DEVELOPMENT 126
15.2 BD 127
15.2.1 COMPANY SNAPSHOT 127
15.2.2 REVENUE ANALYSIS 127
15.2.3 COMPANY SHARE ANALYSIS 128
15.2.4 PRODUCT PORTFOLIO 128
15.2.5 RECENT DEVELOPMENT 128
15.3 F. HOFFMANN- LA ROCHE LTD 129
15.3.1 COMPANY SNAPSHOT 129
15.3.2 REVENUE ANALYSIS 129
15.3.3 COMPANY SHARE ANALYSIS 130
15.3.4 PRODUCT PORTFOLIO 130
15.3.5 RECENT DEVELOPMENT 130
15.4 ABBOTT 131
15.4.1 COMPANY SNAPSHOT 131
15.4.2 REVENUE ANALYSIS 131
15.4.3 COMPANY SHARE ANALYSIS 132
15.4.4 PRODUCT PORTFOLIO 132
15.4.5 RECENT DEVELOPMENTS 132
15.5 HOLOGIC, INC. 133
15.5.1 COMPANY SNAPSHOT 133
15.5.2 REVENUE ANALYSIS 133
15.5.3 COMPANY SHARE ANALYSIS 134
15.5.4 PRODUCT PORTFOLIO 134
15.5.5 RECENT DEVELOPMENTS 134
15.6 ARBOR VITA CORPORATION 135
15.6.1 COMPANY SNAPSHOT 135
15.6.2 PRODUCT PORTFOLIO 135
15.6.3 RECENT DEVELOPMENTS 135
15.7 BIO-RAD LABORATORIES, INC. 136
15.7.1 COMPANY SNAPSHOT 136
15.7.2 REVENUE ANALYSIS 136
15.7.3 PRODUCT PORTFOLIO 137
15.7.4 RECENT DEVELOPMENT 137
15.8 GENOMEME LAB INC. 138
15.8.1 COMPANY SNAPSHOT 138
15.8.2 PRODUCT PORTFOLIO 138
15.8.3 RECENT DEVELOPMENTS 138
15.9 GUIDED THERAPEUTICS, INC 139
15.9.1 COMPANY SNAPSHOT 139
15.9.2 REVENUE ANALYSIS 139
15.9.3 PRODUCT PORTFOLIO 140
15.9.4 RECENT DEVELOPMENT 140
15.10 JIANGSU MOLE BIOSCIENCE CO., LTD. 141
15.10.1 COMPANY SNAPSHOT 141
15.10.2 PRODUCT PORTFOLIO 141
15.10.3 RECENT DEVELOPMENTS 141
15.11 LCM GENECT SRL 142
15.11.1 COMPANY SNAPSHOT 142
15.11.2 PRODUCT PORTFOLIO 142
15.11.3 RECENT DEVELOPMENT 142
15.12 MOBILEODT 143
15.12.1 COMPANY SNAPSHOT 143
15.12.2 PRODUCT PORTFOLIO 143
15.12.3 RECENT DEVELOPMENT 143
15.13 QIAGEN 144
15.13.1 COMPANY SNAPSHOT 144
15.13.2 REVENUE ANALYSIS 144
15.13.3 PRODUCT PORTFOLIO 145
15.13.4 RECENT DEVELOPMENTS 145
15.14 QUEST DIAGNOSTICS INCORPORATED 146
15.14.1 COMPANY SNAPSHOT 146
15.14.2 REVENUE ANALYSIS 146
15.14.3 PRODUCT PORTFOLIO 147
15.14.4 RECENT DEVELOPMENTS 147
15.15 SEEGENE INC. 148
15.15.1 COMPANY SNAPSHOT 148
15.15.2 PRODUCT PORTFOLIO 148
15.15.3 RECENT DEVELOPMENTS 148
15.16 SYSMEX CORPORATION 149
15.16.1 COMPANY SNAPSHOT 149
15.16.2 PRODUCT PORTFOLIO 149
15.16.3 RECENT DEVELOPMENT 150
15.17 THE COOPER COMPANIES INC 151
15.17.1 COMPANY SNAPSHOT 151
15.17.2 REVENUE ANALYSIS 151
15.17.3 PRODUCT PORTFOLIO 152
15.17.4 RECENT DEVELOPMENT 152
15.18 ZILICO 153
15.18.1 COMPANY SNAPSHOT 153
15.18.2 PRODUCT PORTFOLIO 153
15.18.3 RECENT DEVELOPMENT 153
16 QUESTIONNAIRE 154
17 RELATED REPORTS 157
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.